Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures

J Neuroimmunol. 2004 Aug;153(1-2):36-9. doi: 10.1016/j.jneuroim.2004.04.009.

Abstract

Convulsions are common complications of shigellosis in children. Corticotropin-releasing hormone (CRH), a stress neurohormone, has been implicated in the susceptibility of young children to seizures. We investigated the role of CRH in Shigella-related seizures. Pretreatment with Shigella dysenteriae sonicate enhanced mice response to pentylenetetrazole (PTZ)-induced seizures. Preinjection of antalarmin, a CRH-receptor 1 antagonist, decreased both the mean convulsion score (MCS: 1.6 vs. 1.1, p<0.05) and the percent of mice having seizures (48% vs. 28%, p=0.03). This indicates that CRH plays a role in the increased susceptibility to seizures following exposure to S. dysenteriae.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corticotropin-Releasing Hormone / metabolism*
  • Corticotropin-Releasing Hormone / physiology
  • Disease Models, Animal
  • Male
  • Mice
  • Mice, Inbred ICR
  • Pentylenetetrazole
  • Pyrimidines / therapeutic use
  • Pyrroles / therapeutic use
  • Seizures / chemically induced
  • Seizures / metabolism*
  • Seizures / microbiology*
  • Seizures / prevention & control
  • Shigella*
  • Time Factors

Substances

  • Pyrimidines
  • Pyrroles
  • antalarmin
  • Corticotropin-Releasing Hormone
  • Pentylenetetrazole